SCHEMBL18909253

SCHEMBL18909253

CCC(=O)N1CCN(CC2CCN(CC(=O)N(C)C)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
CACNA2D1 P54289 2/20 0.41
CACNA1B Q00975 2/20 0.41
CACNB1 Q02641 2/20 0.41
CACNA1C Q13936 1/20 0.41
PKM P14618 1/20 0.39
HSD11B1 P28845 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
BDKRB1 P46663 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
THRB P10828 1/20 0.35
EPHX2 P34913 2/20 0.35
HTR4 Q13639 1/20 0.35
NPY1R P25929 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18909219 0.96 ALDH1A1 (0.52) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL24521453 0.88 ALDH1A1 (0.54) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL12847187 0.87 ALDH1A1 (0.70) ALDH1A1PKMSMN1; SMN2
SCHEMBL18023792 0.85 ALDH1A1 (0.45) ALDH1A1PKMHSD11B1KDM4ESMN1; SMN2
SCHEMBL22030928 0.85 ALDH1A1 (0.52) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL19259563 0.83 ALDH1A1 (0.51) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL17286057 0.82 ALDH1A1 (0.45) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL18909223 0.82 SIGMAR1 (0.44) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL25701777 0.82 HSD11B1 (0.53) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL20471042 0.82 HRH3 (0.48) ALDH1A1CACNA2D1CACNA1BCACNB1CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed